Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pro-MPX prospective observational monkeypox cohort study
NL-OMON51810Active, not recruiting
- Sponsor
- Public Health Service of Amsterdam
- Start
- Sep 2022
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of JYNNEOS in mpox (2 arms), sponsored by Public Health Service of Amsterdam. Primary endpoint: Time to resolution of symptoms. Started Sep 2022; status: active, not recruiting.
02
Drugs
JYNNEOS
03
Conditions
mpox
Beyond the preview
Go deeper on NL-OMON51810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51810.